Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-09

FDA Approved: CAVERJECT — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved Pharmacia & Upjohn’s supplemental application for CAVERJECT (alprostadil). This constitutes an approved supplemental submission to the original…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAVERJECT (ALPROSTADIL)

Snippet

SUPPL AP for CAVERJECT (ALPROSTADIL)